Exhibit 3
SECOND AMENDED AND RESTATED JOINT FILING AGREEMENT
THIS SECOND AMENDED AND RESTATED JOINT FILING AGREEMENT is entered into as
of April 4, 2005, by and among the parties signatories hereto. This Second
Amended and Restated Joint Filing Agreement amends and restates the Amended and
Restated Joint Filing Agreement, dated August 29, 2003, filed as Exhibit A to
Amendment No. 6 of the Schedule 13D filed on September 3, 2003 (the "Statement
on Schedule 13D").
The undersigned hereby agree that the Statement on Schedule 13D with
respect to the shares of common stock, par value $0.001 per share, of Micro
Therapeutics, Inc., a Delaware corporation, is, and any amendment thereafter
signed by each of the undersigned shall be, filed on behalf of each undersigned
pursuant to and in accordance with the provisions of 13d-1(k) under the
Securities Exchange Act of 1934, as amended.
Dated: April 4, 2005 EV3 LLC
By: /s/ Xxxxx X. Xxxxxxx
--------------------------------
Name: Xxxxx X. Xxxxxxx
Title: President and Chief
Executive Officer
Dated: April 4, 2005 MICRO INVESTMENT, LLC
By: ev3 LLC, Managing Member
By: /s/ Xxxxx X. Xxxxxxx
--------------------------------
Name: Xxxxx X. Xxxxxxx
Title: President and Chief
Executive Officer
Dated: April 4, 2005 WARBURG, XXXXXX EQUITY PARTNERS, L.P.
By: Warburg Pincus Partners LLC,
its General Partner
By: Warburg Pincus & Co.,
its Managing Member
By: /s/ Xxxx X. Xxxxxx
--------------------------------
Name: Xxxx X. Xxxxxx
Title: Partner
Dated: April 4, 2005 WARBURG PINCUS & CO.
By: /s/ Xxxx X. Xxxxxx
--------------------------------
Name: Xxxx X. Xxxxxx
Title: Partner
Dated: Xxxxx 0, 0000 XXXXXXX PINCUS LLC
By: /s/ Xxxx X. Xxxxxx
--------------------------------
Name: Xxxx X. Xxxxxx
Title: Member
Dated: April 4, 2005 WARBURG PINCUS PARTNERS LLC
By: Warburg Pincus & Co.,
its Managing Member
By: /s/ Xxxx X. Xxxxxx
--------------------------------
Name: Xxxx X. Xxxxxx
Title: Partner